Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

XLOXLO
Showing 8 of 19 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in XILIO THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 39,055 shares of XLO (XILIO THERAPEUTICS INC), worth $374,174 as of 2026-Q2. The position was increased (+5.0% shares).

Current Value

$374,174

Current Shares

39,055

Total Value Change

+$107,754

Total Shares Change

-299,137

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
39,055
+5.0%
$374,1740.0%$9.58
17
2026-Q1
Decreased
37,197
-88.7%
$312,8480.0%$0.53
0
2025-Q4
Unchanged
328,972
0.0%
$210,6300.0%$0.65
0
2025-Q3
Decreased
328,972
-11.0%
$277,2570.0%$0.86
0
2025-Q2
Decreased
369,660
-2.5%
$251,3550.0%$0.68
0
2025-Q1
Increased
379,016
+5.8%
$274,5900.0%$0.75
17
2024-Q4
Increased
358,422
+6.0%
$342,3340.0%$0.97
17
2024-Q3
Increased
338,192
+85.0%
$266,4200.0%$0.76
25

Other major holders of XLO: RA CAPITAL MANAGEMENT, L.P., NORGES BANK, FIL Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used